국가: 캐나다
언어: 영어
출처: Health Canada
ERYTHROMYCIN
ODAN LABORATORIES LTD
S01AA17
ERYTHROMYCIN
5MG
OINTMENT
ERYTHROMYCIN 5MG
OPHTHALMIC
1G/3.5G
Prescription
ANTIBACTERIALS
Active ingredient group (AIG) number: 0105708001; AHFS:
APPROVED
2015-07-31
PRESCRIBING INFORMATION PR ODAN-ERYTHROMYCIN ERYTHROMYCIN OPHTHALMIC OINTMENT, USP 5 MG / G ANTIBIOTIC ODAN LABORATORIES LTD. 325 Stillview Ave., Pointe Claire, Québec H9R 2Y6 Submission Control No: 211571 Date of Revision: January 5, 2018 www.odanlab.com 1 PRESCRIBING INFORMATION PR ODAN-ERYTHROMYCIN ERYTHROMYCIN O PHTHALMIC OINTMENT, USP 5 MG / G THERAPEUTIC CLASSIFICATION Antibiotic ACTION AND CLINICAL PHARMACOLOGY Erythromycin inhibits protein synthesis by binding to the 50S ribosomal subunit within the microorganism. It is usually bacteriostatic but may be bactericidal depending on the sensitivity and number of organisms and the concentrations of the drug. Its spectrum of activity is similar to that of penicillin G. Resistance to erythromycin of some strains of H. influenza and Staphylococci has been demonstrated. INDICATIONS For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin. For prophylaxis of ophthalmic neonatorum due to N. gonorrhoeae or C. trachomatis. The Canadian Pediatric Society, the Centers for Diseases Control and the Committee on Drugs (US), the Committee of Fetus and Newborn and the Committee on Infectious Diseases of the American Academy of Pediatrics recommend 1% silver nitrate solution in single dose ampoules or single use tubes of an ophthalmic ointment containing 0.5% erythromycin or 1% tetracycline as effective and acceptable regimens for prophylaxis of gonococcal ophthalmia neonatorum. Erythromycin ophthalmic ointment has also been effective for prevention of neonatal conjunctivitis due to C. trachomatis, a condition that may develop one to several weeks after delivery in infants of mothers whose birth canal harbor the organism. To reduce the development of drug-resistant bacteria and maintain the effectiveness of ODAN- ERYTHROMYCIN and other antibacterial drugs, ODAN-ERYTHROMYCIN should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When c 전체 문서 읽기